Mukka Proteins: The financial results for the period ended September 30, 2026
Mukka Proteins (MUKKA) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹785 crore.
What happened
Mukka Proteins (MUKKA) filed a disclosure with the exchanges on 7 November 2026 at 12:50 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
Mukka Proteins is a micro-cap company, with a market value of about ₹785 crore.
The stock last traded at ₹26.15, against a 52-week range of ₹18.27–₹33.29 (21.4% below the high).
Before this filing the shares had moved −3.0% over the month and +13.2% over three months. Average daily turnover over the last 20 sessions was about ₹0.5 crore.
Promoters held 73.33% at the end of Q1 FY27. Foreign institutions owned 1.73% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 171 | 1.5 | 0.05 |
| Q2 FY26 | 245 | 5.9 | 0.2 |
| Q3 FY26 | 653 | 23.7 | 0.79 |
| Q4 FY26 | 381 | 20.6 | 0.69 |
| Q1 FY27 | 490 | 18.9 | 0.63 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
Market-wide, 10,949 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 7 November 2026: Board meeting — Financial Results.
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.